
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type from the provided ranked marker list, I will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **BMP7**: Part of the bone morphogenetic protein family, involved in development and cellular growth.<br>- **GDF15**: A member of the TGF-beta superfamily, often associated with stress response and inflammation.<br>- **S100A7**: Also known as Psoriasin, involved in immune response and inflammation.<br>- **STEAP4**: Involved in metal ion transport and metabolism.<br>- **TFF1, TFF3**: Trefoil factors involved in mucosal protection and repair.<br>- **PTGES**: Prostaglandin E synthase, involved in inflammation and cancer progression.<br>- **KLF4**: A transcription factor involved in cell differentiation and proliferation.<br>- **INSR**: Insulin receptor, involved in metabolic regulation.<br>- **S100A9**: Involved in immune response and inflammation.<br><br>### Step 2: List the Key Cell Type Markers<br>- **SCGB2A2 (Mammaglobin)**: Highly specific to breast tissue, often used as a marker for breast epithelial cells.<br>- **SCGB3A1**: Secretoglobin family member, associated with epithelial cells.<br>- **TFF1, TFF3**: Often expressed in epithelial tissues, including breast tissue.<br>- **S100P**: Frequently expressed in breast cancer and other epithelial cancers.<br>- **CD24**: A marker often associated with epithelial and cancer stem cells.<br>- **OCLN (Occludin)**: A tight junction protein, indicative of epithelial cells.<br>- **ZNF217**: A zinc finger protein often amplified in breast cancer.<br>- **TFAP2C**: A transcription factor involved in the regulation of genes in breast cancer.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer scRNA-seq, the markers SCGB2A2, TFF1, TFF3, and S100P are strongly associated with breast epithelial cells, particularly luminal epithelial cells. CD24 is also a common marker for epithelial and cancer stem cells in breast tissue.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of SCGB2A2, TFF1, TFF3, and S100P, the most probable general cell type is **breast epithelial cells**. These markers are highly indicative of luminal epithelial cells in the breast.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Luminal Epithelial Cells**: The presence of SCGB2A2, TFF1, and TFF3 strongly suggests luminal epithelial cells, which are a major component of breast tissue.<br>2. **Luminal Progenitor Cells**: Given the expression of CD24 and S100P, these could also represent luminal progenitor cells, which are precursors to mature luminal cells.<br>3. **Basal Epithelial Cells**: Although less likely, the presence of some markers like CD24 could also suggest basal epithelial cells, but the lack of specific basal markers makes this less probable.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of **luminal epithelial cells**. The expression of SCGB2A2, TFF1, TFF3, and S100P, along with other epithelial markers, supports this annotation. The top three probable subtypes are luminal epithelial cells, luminal progenitor cells, and basal epithelial cells, with luminal epithelial cells being the most likely subtype.<br><br>**FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency**: <br>   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. <br>   - The markers SCGB2A2, TFF1, TFF3, and S100P are strongly associated with breast epithelial cells, particularly luminal epithelial cells, which aligns with the annotation.<br><br>2. **Mixed Cell Type Consideration**:<br>   - The annotation considers the possibility of mixed cell types by identifying potential subtypes such as luminal epithelial cells, luminal progenitor cells, and basal epithelial cells.<br>   - The presence of CD24 and S100P supports the consideration of luminal progenitor cells, while the lack of specific basal markers makes basal epithelial cells less probable.<br><br>Overall, the annotation is well-supported by the marker list and the analysis provided. The identification of luminal epithelial cells as the primary cell type is appropriate given the expression of the key markers.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">breast epithelial cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>luminal epithelial cells</li><li>luminal progenitor cells</li><li>basal epithelial cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a strong understanding of the marker list and its relevance to breast cancer cell types. The analysis correctly identifies the main cell type as breast epithelial cells, with a focus on luminal epithelial cells, which is supported by the presence of key markers such as SCGB2A2, TFF1, TFF3, and S100P. These markers are well-known to be associated with luminal epithelial cells in breast tissue, indicating a high level of scientific accuracy in the annotation.<br><br>The annotation also considers the possibility of mixed cell types by identifying potential subtypes, including luminal progenitor cells and basal epithelial cells. This shows a balanced consideration of multiple markers and acknowledges the complexity of the cell population. The inclusion of CD24 and S100P supports the consideration of luminal progenitor cells, while the lack of specific basal markers makes the identification of basal epithelial cells less probable, which is appropriately noted.<br><br>One potential area for improvement is the consideration of the rank of the markers. While the analysis does a good job of identifying key markers, it could place more emphasis on the markers that appear earlier in the list, as these may have higher expression levels or significance in the dataset. However, the overall annotation captures the general picture of the cell populations effectively and does not exhibit any obvious misclassifications or oversights.<br><br>In summary, the annotation is scientifically accurate, well-balanced in its use of different markers, and provides a comprehensive view of the cell types present in the dataset. The analysis is thorough and well-reasoned, with only minor room for improvement in considering marker rank.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    